Treatment of patients with visceral candidiasis

AIM: To study effectiveness of antimycotic medication with flucostat in patients with visceral candidiasis. MATERIAL AND METHODS: Diagnosis of bronchopulmonary, gastrointestinal, urogenital candidiasis was verified microbiologically in 152 patients aged 20 to 78 years. Candidiasis was treated with flucostat: 50 mg and 150 mg capsules per os and solution (100-50 ml) intravenously by dropper. RESULTS: The response was achieved in 140 (92.1%) patients: cure--in 107 (70.4%), improvement--in 33 (21.7%), mycological sanation--in 125 (82.2%) patients. CONCLUSION: Cure of chronic diseases complicated by mycotic infection is not always achieved after mycotic sanation. Some symptoms of severe chronic pathology persist and require long-term symptomatic treatment.